Warfarin therapy not warranted for secondary prevention of CVD: Warfarin is no better than aspirin for preventing recurrent ischemic strokes.

Long Wong; Dan Criswell

Warfarin therapy not warranted for secondary prevention of CVD: Warfarin is no better than aspirin for preventing recurrent ischemic strokes.

Long Wong, Dan Criswell

Institute for Healthy Aging

Research output: Contribution to journal › Short survey › peer-review

Original language	English
Pages (from-to)	1-2
Number of pages	2
Journal	Evidence-Based Practice
Volume	12
Issue number	12
State	Published - 2009

Cite this

@article{8153bb4674e445608fa8d1bc62e26a58,

title = "Warfarin therapy not warranted for secondary prevention of CVD: Warfarin is no better than aspirin for preventing recurrent ischemic strokes.",

author = "Long Wong and Dan Criswell",

year = "2009",

language = "English",

volume = "12",

pages = "1--2",

journal = "Evidence-Based Practice",

issn = "1095-4120",

publisher = "Dowden Health Media,Inc",

number = "12",

}

TY - JOUR

T1 - Warfarin therapy not warranted for secondary prevention of CVD

T2 - Warfarin is no better than aspirin for preventing recurrent ischemic strokes.

AU - Wong, Long

AU - Criswell, Dan

PY - 2009

Y1 - 2009

UR - http://www.scopus.com/inward/record.url?scp=77951887074&partnerID=8YFLogxK

M3 - Short survey

AN - SCOPUS:77951887074

SN - 1095-4120

VL - 12

SP - 1

EP - 2

JO - Evidence-Based Practice

JF - Evidence-Based Practice

IS - 12

ER -

Warfarin therapy not warranted for secondary prevention of CVD: Warfarin is no better than aspirin for preventing recurrent ischemic strokes.

Other files and links

Cite this